BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.44	29.85	65.22	193.73	232.97	213.12
Cash & Short-Term Investments	17.44	29.85	65.22	193.73	232.97	213.12
Cash Growth	-69.02%	-54.23%	-66.33%	-16.84%	9.31%	557.25%
Accounts Receivable	0.02	0.13	0.07	0.25	-	-
Receivables	0.02	0.13	0.07	0.25	-	-
Inventory	0.51	0.68	1.99	1.99	-	-
Prepaid Expenses	5.15	5.29	2.78	3.07	2.89	2.96
Other Current Assets	1	1.44	2.08	3.84	0.96	0.98
Total Current Assets	25.24	37.39	72.14	202.87	236.81	217.07
Property, Plant & Equipment	0.55	0.86	1.47	2.06	2.54	2.78
Other Long-Term Assets	-	0.09	0.09	0.93	0.09	0.09
Total Assets	25.79	38.34	73.7	205.85	239.44	219.94
Accounts Payable	16.69	15.99	13.65	10.23	4.68	3.98
Accrued Expenses	5.1	5.78	13.15	22.18	11.39	6.93
Current Portion of Leases	0.26	0.37	-	-	-	-
Current Income Taxes Payable	0.11	0.09	0.12	0.08	0.3	0.7
Other Current Liabilities	-	-	0.35	0.4	0.29	0.24
Total Current Liabilities	33.38	22.23	27.27	32.9	16.67	11.84
Long-Term Debt	97.47	102.51	100.6	93.05	-	-
Long-Term Leases	-	0.07	0.44	0.79	1.11	1.4
Other Long-Term Liabilities	2.61	6.63	1.91	2.34	-	-
Total Liabilities	133.46	131.44	130.21	129.08	17.77	13.24
Common Stock	0.06	0.05	0.03	0.03	0.03	0.02
Additional Paid-In Capital	568.91	557.05	534.06	488.29	467.43	345.53
Retained Earnings	-676.64	-650.2	-590.6	-411.55	-245.79	-138.86
Shareholders' Equity	-107.67	-93.1	-56.51	76.78	221.67	206.7
Total Liabilities & Equity	25.79	38.34	73.7	205.85	239.44	219.94
Total Debt	108.94	102.95	101.04	93.84	1.11	1.4
Net Cash (Debt)	-91.51	-73.09	-35.82	99.89	231.86	211.72
Net Cash Growth	-	-	-	-56.92%	9.51%	574.34%
Net Cash Per Share	-19.91	-28.83	-19.67	57.05	140.67	156.23
Filing Date Shares Outstanding	14.56	5.49	1.91	1.81	1.75	1.54
Total Common Shares Outstanding	6.62	3.1	1.87	1.76	1.75	1.53
Working Capital	-8.13	15.16	44.88	169.97	220.15	205.22
Book Value Per Share	-16.26	-30.01	-30.21	43.64	126.76	135.44
Tangible Book Value	-107.67	-93.1	-56.51	76.78	221.67	206.7
Tangible Book Value Per Share	-16.26	-30.01	-30.21	43.64	126.76	135.44
Machinery	0.78	0.78	0.78	0.79	0.74	0.63
Construction In Progress	-	-	-	-	0.02	0.36
Leasehold Improvements	1.2	1.2	1.2	1.18	1.13	0.65

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q